Department of Defense - Army

Form 483 issued May 9, 2025

Inspection
May 5 – May 9, 2025
Investigator
Steven D. Banks
Observations
2
Pages
3
FEI number
1077442

In short: On May 9, 2025, FDA issued a Form 483 with 2 observations to Department of Defense - Army (FEI 1077442) after an inspection that ran May 5 – May 9, 2025. The investigator was Steven D. Banks. Most observations concern biologics CGMP; the most-cited regulation is 21 CFR 640.4 (collection of the blood).

At a glance

2 of 2 observations on this 483 concern biologics cgmp.

Biologics CGMP2

Most cited: 21 CFR 640.4 (1×) · 606.100 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The phlebotomy site is not prepared by a method that gives maximum assurance of a sterile…

  2. 02

    Written standard operating procedures including all steps to be followed in the distribution of blood and…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Department of Defense - Army?

FDA listed 2 observations on this Form 483, mostly about biologics CGMP. The most-cited regulation is 21 CFR 640.4 (collection of the blood). The opening words of each observation are shown on this page.

Who inspected Department of Defense - Army?

Steven D. Banks is named on this Form 483, for the inspection of May 5 – May 9, 2025. Each investigator has a profile showing what they cite most.

When was Department of Defense - Army inspected by FDA?

The inspection ran May 5 – May 9, 2025, and the Form 483 is dated May 9, 2025.

How do I get the full Form 483 for Department of Defense - Army?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free